The Return of Part 11
This article was originally published in The Gold Sheet
Executive Summary
FDA July 7 alerted industry that the agency will soon begin conducting inspections focused on compliance with its March 1997 Part 11 rule on electronic records and electronic signatures
You may also be interested in...
Latest FDA Drug GMP Warning Letters Target CEOs, Contract Manufacturers
Six of FDA's last nine drug GMP warning letters went to contract manufacturing facilities, including firms making OTC drugs and dietary supplements.
CEOs and Contract Manufacturers Targeted in Latest Warning Letters
FDA sent six of its last nine drug GMP warning letters to contract manufacturing facilities. Most of the letters emphasized corporate accountability, and many went directly to CEOs.
Balancing Innovation And Safety – The US and Australian Medtech Regulatory Systems Compared
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: